111
Participants
Start Date
May 31, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
August 31, 2013
AMG 747
Three dose levels once-daily oral administration
Placebo
Once-daily oral administration
Research Site, New York
Research Site, Buffalo
Research Site, Scranton
Research Site, Rockville
Research Site, Durham
Research Site, Nîmes
Research Site, Atlanta
Research Site, Ipoh
Research Site, Ipoh
Research Site, Hialeah
Research Site, Kissimmee
Research Site, Memphis
Research Site, Dôle
Research Site, Flowood
Research Site, Kuala Lumpur
Research Site, Kuala Lumpur
Research Site, Kuala Lumpur
Research Site, Little Rock
Research Site, Springdale
Research Site, Dallas
Research Site, Montauban
Research Site, Long Beach
Research Site, Orange
Research Site, Créteil
Research Site, Oakland
Research Site, Princeton
Research Site, Brno
Research Site, Olomouc
Research Site, Prague
Research Site, Prague
Research Site, Přerov
Research Site, Strakonice
Research Site, Bydgoszcz
Research Site, Chełmno
Research Site, Katowice
Research Site, Skorzewo
Research Site, Torun
Research Site, Żuromin
Research Site, Barnet
Research Site, Edinburgh
Research Site, London
Research Site, Norwich
Research Site, Sheffield
Research Site, Warrington
Lead Sponsor
Amgen
INDUSTRY